The effectiveness of cryolipolysis in excess local fat deposits

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective. Evaluation of the effectiveness and safety of cryolipolysis based on a comparative analysis of soft tissue ultrasound data. Methods. This study presents the results of using cryolipolysis for excess localized fat deposits based on ultrasound data. The study group included 62 patients with complaints of excessive local fat deposits. The first control group consisted of 10 patients who followed the dietitian’s recommendations. The first main group included 8 patients who underwent cryolipolysis of one anatomical area, with a total area of about 160 cm2, or two anatomical areas, with an area of 80 cm2 each. The second main group included 24 patients with excessive local fat deposits, who underwent 2 consecutive cryolipolysis procedures according to the Treatment to Transformation (T2T) protocol. Results. Efficiency in groups where cryolipolysis was used was significantly higher. At the same time, in men, the effect occurred later than in women - only after 10 weeks. Conclusion. In general, women tolerated the procedure more easily, less often complained of soreness, swelling, and hyperesthesia at the site of the procedure.

Texto integral

Acesso é fechado

Sobre autores

Sergey Surkichin

Polyclinic №. 2 of the Administrative Department of the President of the Russian Federation; Central State Medical Academy of the Administrative Department of the President of the Russian Federation

Email: surkichinsi24@mail.ru
Cand. Sci. (Med.), Head of the Department of Dermatovenereology and Cosmetology; Department of Dermatovenereology and Cosmetology Moscow, Russia

E. Kruglik

Central State Medical Academy of the Administrative Department of the President of the Russian Federation

Moscow, Russia

Bibliografia

  1. Ожирение и избыточный вес. ВОЗ. Информационный бюллетень № 311, март 2011. С. 1-11.
  2. Рациональная фармакотерапия заболеваний эндокринной системы и нарушений обмена веществ: Руководство для практических врачей. Под ред. И.И. Дедова, ГА. Мельниченко. М., 2006.1080.
  3. Cawley J, Ruhm C. The Economics of Risky Health Behaviors. NBER Working Paper N17081, May 2011, and published as chapter 3 in Handbook of Health Economics. Eds. McGuire T.G., Pauly M.V., PP Barros. New York: Elsevier. 2012;2:95-199.
  4. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of Overweight and Obesity in the United States, 1999-2004. JAMA. 2006;295:1549-55.
  5. Food and health in Europe: a new basis for action. WHO Regional Publications. Eur Ser. 2004;1:91-8.
  6. Бутрова С.А., Берковская М.А. Распространенность абдоминального ожирения, метаболического синдрома, кардиометаболических факторов риска и сахарного диабета среди женщин различных возрастных групп. Материалы V Российского симпозиума с международным участием «Хирургическое лечение ожирения и метаболических нарушений». Самара, 2009. С. 28-33.
  7. Бессесен Д.Г, Кушнер Р. Избыточный вес и ожирение. Профилактика, диагностика и лечение. М., 2004. 240 с.
  8. Аметов А.С. Избранные лекции по эндокринологии. М., 2011. 544 с.
  9. Аметов А.С. Сахарный диабет 2 типа. Проблемы и решения. М., 2011. 704 с.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2022

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies